BeOne Medicines (ONC) Interest & Investment Income (2015 - 2026)
BeOne Medicines (ONC) reported Interest & Investment Income of $27.7 million for Q1 2026, up 115.28% year-over-year from $12.8 million in Q1 2025, and down 52.41% on a QoQ basis from $58.1 million in Q4 2025.
BeOne Medicines (ONC) has 6 years of Interest & Investment Income data on file, last reported at $27.7 million in Q1 2026.
- Quarterly Interest & Investment Income rose 115.28% year-over-year to $27.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $92.3 million (up 39.18% YoY) and the FY2025 annual result came in at $70.5 million, up 1.24% from the prior year.
- Interest & Investment Income fell to $27.7 million in Q1 2026 per ONC's latest filing, from $58.1 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $58.1 million in Q4 2025 and bottomed at $3.0 million in Q3 2025.
- The 4-year median for Interest & Investment Income is $16.2 million (2024), against an average of $20.2 million.
- The widest annual swing landed in 2025, when Interest & Investment Income slumped 73.56%; it then soared 115.28% in 2026.
- Tracing ONC's Interest & Investment Income over 4 years: stood at $20.6 million in 2023, then soared by 43.49% to $29.6 million in 2024, then soared by 96.3% to $58.1 million in 2025, then tumbled by 52.41% to $27.7 million in 2026.
- Per Business Quant, the three latest ONC Interest & Investment Income figures stand at $27.7 million (Q1 2026), $58.1 million (Q4 2025), and $3.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 305,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 26.60 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 27.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.66 Mn |
| Dec 31, 2025 | 58.13 Mn |
| Sep 30, 2025 | 3.03 Mn |
| Jun 30, 2025 | 3.50 Mn |
| Mar 31, 2025 | 12.85 Mn |
| Dec 31, 2024 | 29.61 Mn |
| Sep 30, 2024 | 10.64 Mn |
| Jun 30, 2024 | 13.23 Mn |
| Mar 31, 2024 | 16.16 Mn |
| Dec 31, 2023 | 20.64 Mn |
| Sep 30, 2023 | 26.65 Mn |
| Sep 30, 2016 | 209,000.00 |
| Jun 30, 2016 | 262,000.00 |
| Mar 31, 2016 | 494,000.00 |
| Sep 30, 2015 | 760,000.00 |
| Jun 30, 2015 | 409,000.00 |
| Mar 31, 2015 | 117,000.00 |